| Year |
Citation |
Score |
| 2022 |
Qiu SB, Liu PY, Wang BC, Chen PR, Xiao JH, Hsu TY, Pan KL, Lai ZY, Chen YW, Chen YC, Chen JK, Pan PS. Protection-Free Strategy for the Synthesis of Boro-Depsipeptides in Aqueous Media under Microwave-Assisted Conditions. Molecules (Basel, Switzerland). 27. PMID 35408725 DOI: 10.3390/molecules27072325 |
0.338 |
|
| 2009 |
Molander GA, Cavalcanti LN, Canturk B, Pan PS, Kennedy LE. Efficient hydrolysis of organotrifluoroborates via silica gel and water. The Journal of Organic Chemistry. 74: 7364-9. PMID 19743828 DOI: 10.1021/Jo901441U |
0.314 |
|
| 2009 |
Pan PS, Vasko RC, Lapera SA, Johnson VA, Sellers RP, Lin CC, Pan CM, Davis MR, Ardi VC, McAlpine SR. A comprehensive study of Sansalvamide A derivatives: The structure-activity relationships of 78 derivatives in two pancreatic cancer cell lines. Bioorganic & Medicinal Chemistry. 17: 5806-25. PMID 19643615 DOI: 10.1016/J.Bmc.2009.07.017 |
0.715 |
|
| 2008 |
Singh EK, Ravula S, Pan CM, Pan PS, Vasko RC, Lapera SA, Weerasinghe SV, Pflum MK, McAlpine SR. Synthesis and biological evaluation of histone deacetylase inhibitors that are based on FR235222: a cyclic tetrapeptide scaffold. Bioorganic & Medicinal Chemistry Letters. 18: 2549-54. PMID 18381239 DOI: 10.1016/J.Bmcl.2008.03.047 |
0.729 |
|
| 2008 |
Davis MR, Styers TJ, Rodriguez RA, Pan PS, Vasko RC, McAlpine SR. Synthesis and cytotoxicity of a new class of potent decapeptide macrocycles. Organic Letters. 10: 177-80. PMID 18095697 DOI: 10.1021/Ol702403R |
0.774 |
|
| 2007 |
Pan PS, McGuire KL, McAlpine SR. Identification of Sansalvamide a analog potent against pancreatic cancer cell lines. Bioorganic & Medicinal Chemistry Letters. 17: 5072-7. PMID 17689077 DOI: 10.1016/J.Bmcl.2007.07.025 |
0.769 |
|
| 2007 |
Rodriguez RA, Pan PS, Pan CM, Ravula S, Lapera S, Singh EK, Styers TJ, Brown JD, Cajica J, Parry E, Otrubova K, McAlpine SR. Synthesis of second-generation sansalvamide A derivatives: novel templates as potential antitumor agents. The Journal of Organic Chemistry. 72: 1980-2002. PMID 17315929 DOI: 10.1021/Jo061830J |
0.698 |
|
| 2006 |
Styers TJ, Kekec A, Rodriguez R, Brown JD, Cajica J, Pan PS, Parry E, Carroll CL, Medina I, Corral R, Lapera S, Otrubova K, Pan CM, McGuire KL, McAlpine SR. Synthesis of Sansalvamide A derivatives and their cytotoxicity in the MSS colon cancer cell line HT-29. Bioorganic & Medicinal Chemistry. 14: 5625-31. PMID 16697205 DOI: 10.1016/J.Bmc.2006.04.031 |
0.736 |
|
| 2006 |
Pan PS, Curtis FA, Carroll CL, Medina I, Liotta LA, Sharples GJ, McAlpine SR. Novel antibiotics: C-2 symmetrical macrocycles inhibiting Holliday junction DNA binding by E. coli RuvC. Bioorganic & Medicinal Chemistry. 14: 4731-9. PMID 16581254 DOI: 10.1016/J.Bmc.2006.03.028 |
0.719 |
|
| 2006 |
Otrubova K, Styers TJ, Pan PS, Rodriguez R, McGuire KL, McAlpine SR. Synthesis and novel structure-activity relationships of potent sansalvamide A derivatives. Chemical Communications (Cambridge, England). 1033-4. PMID 16491200 DOI: 10.1039/B517434A |
0.802 |
|
| 2006 |
Styers TJ, Rodriguez R, Pan PS, McAlpine SR. High-yielding macrocyclization conditions used in the synthesis of novel Sansalvamide A derivatives Tetrahedron Letters. 47: 515-517. DOI: 10.1016/J.Tetlet.2005.11.056 |
0.642 |
|
| 2005 |
Carroll CL, Johnston JV, Kekec A, Brown JD, Parry E, Cajica J, Medina I, Cook KM, Corral R, Pan PS, McAlpine SR. Synthesis and cytotoxicity of novel sansalvamide A derivatives. Organic Letters. 7: 3481-4. PMID 16048322 DOI: 10.1021/Ol051161G |
0.833 |
|
| 2004 |
Liotta LA, Medina I, Robinson JL, Carroll CL, Pan PS, Corral R, Johnston JVC, Cook KM, Curtis FA, Sharples GJ, McAlpine SR. Novel antibiotics: Second generation macrocyclic peptides designed to trap Holliday junctions Tetrahedron Letters. 45: 8447-8450. DOI: 10.1016/J.Tetlet.2004.09.084 |
0.674 |
|
| Show low-probability matches. |